These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35452975)

  • 1. Association between preoperative skeletal muscle mass depletion and poor relapse-free survival in patients with gastrointestinal stromal tumors after complete resection.
    Jia J; Zhang L; Wang T; Yang W; Lyu J; Zeng X; Li X; Zeng X; Liu W; Tao K; Zhang P
    Nutrition; 2022 Jun; 98():111636. PubMed ID: 35452975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Prognostic Nomogram for Recurrence-Free Survival of Patients With Primary Gastrointestinal Stromal Tumors After Surgical Resection: Combination of Prognostic Nutritional Index and Basic Variables.
    Li S; Chen D; Li S; Zhao Z; Yang H; Wang D; Zhang Z; Fu W
    Front Oncol; 2020; 10():581855. PubMed ID: 33585198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcopenia as a novel prognostic factor in the patients of primary localized gastrointestinal stromal tumor.
    Song H; Xiao X; Liu G; Zhou J
    BMC Cancer; 2022 Feb; 22(1):179. PubMed ID: 35177018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic criteria in patients with gastrointestinal stromal tumors: a single center experience retrospective analysis.
    Tanimine N; Tanabe K; Suzuki T; Tokumoto N; Ohdan H
    World J Surg Oncol; 2012 Feb; 10():43. PubMed ID: 22348408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a prognostic nomogram to predict recurrence in high-risk gastrointestinal stromal tumour: A retrospective analysis of two independent cohorts.
    Lin Y; Wang M; Jia J; Wan W; Wang T; Yang W; Li C; Chen X; Cao H; Zhang P; Tao K
    EBioMedicine; 2020 Oct; 60():103016. PubMed ID: 32980695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinogen/Albumin Ratio Index Is an Independent Prognosis Predictor of Recurrence-Free Survival in Patients After Surgical Resection of Gastrointestinal Stromal Tumors.
    Cao X; Cui J; Yu T; Li Z; Zhao G
    Front Oncol; 2020; 10():1459. PubMed ID: 33014783
    [No Abstract]   [Full Text] [Related]  

  • 7. Validation of the MSKCC Gastrointestinal Stromal Tumor Nomogram and Comparison with Other Prognostication Systems: Single-Institution Experience with 289 Patients.
    Chok AY; Goh BK; Koh YX; Lye WK; Allen JC; Quek R; Teo MC; Chow PK; Ong HS; Chung AY; Wong WK
    Ann Surg Oncol; 2015 Oct; 22(11):3597-605. PubMed ID: 25652053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk stratification systems for surgically treated localized primary Gastrointestinal Stromal Tumors (GIST). Review of literature and comparison of the three prognostic criteria: MSKCC Nomogramm, NIH-Fletcher and AFIP-Miettinen.
    Belfiori G; Sartelli M; Cardinali L; Tranà C; Bracci R; Gesuita R; Marmorale C
    Ann Ital Chir; 2015; 86(3):219-27. PubMed ID: 26098671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of fibrinogen and D-dimer-fibrinogen ratio in resectable gastrointestinal stromal tumors.
    Cai HX; Li XQ; Wang SF
    World J Gastroenterol; 2018 Nov; 24(44):5046-5056. PubMed ID: 30510379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive Effectiveness of the Glasgow Prognostic Score for Gastrointestinal Stromal Tumors.
    Maruyama T; Shimoda M; Sako A; Ueda K; Hakoda H; Sakata A; Suzuki S
    Nutr Cancer; 2021; 73(8):1333-1339. PubMed ID: 32748650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of low-density lipoprotein receptor class A domain containing 4 (LDLRAD4) as a prognostic indicator in primary gastrointestinal stromal tumors.
    Xie W; Xiao H; Luo J; Zhao L; Jin F; Ma J; Li J; Xiong K; Chen C; Wang G
    Curr Probl Cancer; 2020 Dec; 44(6):100593. PubMed ID: 32507364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive ability of prognostic nutritional index in surgically resected gastrointestinal stromal tumors: a propensity score matching analysis.
    Shi WK; Zhang XH; Zhang J; Yu M; Yuan YJ; Xiong W; Zhang CH; He YL; Wei ZW
    Jpn J Clin Oncol; 2019 Sep; 49(9):823-831. PubMed ID: 31162583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological and Prognostic Analysis of Primary Gastrointestinal Stromal Tumor Presenting with Gastrointestinal Bleeding: a 10-Year Retrospective Study.
    Yin Z; Gao J; Liu W; Huang C; Shuai X; Wang G; Tao K; Zhang P
    J Gastrointest Surg; 2017 May; 21(5):792-800. PubMed ID: 28275959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive Ability of Blood Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Gastrointestinal Stromal Tumors.
    Racz JM; Cleghorn MC; Jimenez MC; Atenafu EG; Jackson TD; Okrainec A; Venkat Raghavan L; Quereshy FA
    Ann Surg Oncol; 2015 Jul; 22(7):2343-50. PubMed ID: 25472648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nomogram for Predicting Recurrence-Free Survival of Primary Localized Gastrointestinal Stromal Tumor.
    Ran P; Tan T; Zhou H; Li J; Yang H; Li J; Zhang J
    J Pers Med; 2023 Mar; 13(3):. PubMed ID: 36983680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditional disease-free survival after surgical resection of gastrointestinal stromal tumors: a multi-institutional analysis of 502 patients.
    Bischof DA; Kim Y; Dodson R; Jimenez MC; Behman R; Cocieru A; Fisher SB; Groeschl RT; Squires MH; Maithel SK; Blazer DG; Kooby DA; Gamblin TC; Bauer TW; Quereshy FA; Karanicolas PJ; Law CH; Pawlik TM
    JAMA Surg; 2015 Apr; 150(4):299-306. PubMed ID: 25671681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios are independent prognostic factors for surgically resected gastrointestinal stromal tumors.
    Goh BK; Chok AY; Allen JC; Quek R; Teo MC; Chow PK; Chung AY; Ong HS; Wong WK
    Surgery; 2016 Apr; 159(4):1146-56. PubMed ID: 26688506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physician Underestimation of the Risk of Gastrointestinal Stromal Tumor Recurrence After Resection.
    Guérin A; Sasane M; Keir CH; Gauthier G; Macalalad AR; Wu EQ; Conley AP
    JAMA Oncol; 2015 Sep; 1(6):797-805. PubMed ID: 26204106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developed and validated a prognostic nomogram for recurrence-free survival after complete surgical resection of local primary gastrointestinal stromal tumors based on deep learning.
    Chen T; Liu S; Li Y; Feng X; Xiong W; Zhao X; Yang Y; Zhang C; Hu Y; Chen H; Lin T; Zhao M; Liu H; Yu J; Xu Y; Zhang Y; Li G
    EBioMedicine; 2019 Jan; 39():272-279. PubMed ID: 30587460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinicopathological features and prognosis of 59 patients with platelet-derived growth factor α-mutant gastrointestinal stromal tumor].
    Sun XF; Gao XD; Yuan W; Sun JY; Fu M; Xue AW; Li H; Shu P; Fang Y; Hou YY; Shen KT; Sun YH; Qin J; Qin XY
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Sep; 23(9):880-887. PubMed ID: 32927513
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.